Insider Shareholders with Direct Ownership of Olema Pharmaceuticals, Inc. (OLMA)
This section provides a comprehensive overview of the insiders with direct ownership of Olema Pharmaceuticals, Inc. (OLMA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Olema Pharmaceuticals, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
> 10% Shareholder |
1,725,406 | 0 | 1,725,406 $10.9 Million | 1 |
Nov 23, 2020
Added 20.76%
|
|
Peter J. Kushner
CHIEF SCIENTIFIC OFFICER |
502,392 | 0 | 1,431,672 $9.05 Million | 2 |
Nov 23, 2020
Added 8.33%
|
| 259,846 | 399,974 | 764,140 $4.83 Million | 39 |
Dec 11, 2024
Reduced 0.02%
|
|
|
David C. Myles
CH. DISCOV. & NON-CLIN DEV OFF |
218,472 | 80,436 | 598,333 $3.78 Million | 13 |
Dec 11, 2024
Reduced 0.05%
|
|
Shane William Charles Kovacs
CH. OPERATING & FINANCIAL OFF. |
578,680 | 53,901 | 543,549 $3.44 Million | 12 |
Dec 11, 2024
Reduced 0.07%
|
|
Bvf Partners L P
Director |
8,797,617 | 3,369,704 | 370,710 $2.34 Million | 5 |
Dec 04, 2024
Reduced 29.27%
|
|
Sean Bohen
PRESIDENT AND CEO |
396,649 | 176,727 | 241,662 $1.53 Million | 18 |
Dec 11, 2024
Reduced 0.52%
|
|
Frank Mccormick
Director |
152,891 | 0 | 191,113 $1.21 Million | 1 |
Nov 23, 2020
Added 44.44%
|
|
Naseem Zojwalla
CHIEF MEDICAL OFFICER |
153,160 | 42,361 | 129,509 $818,496 | 12 |
Dec 16, 2024
Added 9.76%
|
| 83,876 | 0 | 83,876 $530,096 | 1 |
Sep 16, 2020
Added 50.0%
|
|
|
Kinney Horn
Chief Business Officer |
132,692 | 132,692 | 2,458 $15,534 | 22 |
Mar 10, 2022
Reduced 68.12%
|